Announcement of Beijing Shengxun Electronics Co., Ltd. on Change of Sponsor Institution and Sponsor Representative Post date May 10, 2022 — 08:04 Post Lock Read More Nearly 50% of the company's cash flow has improved Rongyi Finance Post date April 9, 2022 — 12:43 Post Lock Read More Nearly 50% of the company's cash flow has improved Rongyi Finance Post date April 9, 2022 — 12:42 Post Lock Read More Nearly 50% of companies have improved cash flow Post date April 9, 2022 — 01:17 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_Individual Stock Information_Market Gold Online Post date April 8, 2022 — 20:13 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Nearly 50% of the company's cash flow has improved Rongyi Finance Post date April 9, 2022 — 12:43 Post Lock Read More Nearly 50% of the company's cash flow has improved Rongyi Finance Post date April 9, 2022 — 12:42 Post Lock Read More Nearly 50% of companies have improved cash flow Post date April 9, 2022 — 01:17 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_Individual Stock Information_Market Gold Online Post date April 8, 2022 — 20:13 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Nearly 50% of the company's cash flow has improved Rongyi Finance Post date April 9, 2022 — 12:42 Post Lock Read More Nearly 50% of companies have improved cash flow Post date April 9, 2022 — 01:17 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_Individual Stock Information_Market Gold Online Post date April 8, 2022 — 20:13 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Nearly 50% of companies have improved cash flow Post date April 9, 2022 — 01:17 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_Individual Stock Information_Market Gold Online Post date April 8, 2022 — 20:13 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_Individual Stock Information_Market Gold Online Post date April 8, 2022 — 20:13 Post Lock Read More Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Jia Shi Tang: Everbright Group is the strong backing of Jia Shi Tang to promote the development strategy_ Oriental Fortune Net Post date April 8, 2022 — 20:08 Post Lock Read More WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
WHO Says Traditional Chinese Medicine Is Effective in Treating New Coronary Pneumonia, CanSino, CSPC's New Coronary mRNA Vaccine Clinical Trial Applications Approved One After Another Post date April 6, 2022 — 21:19 Post Lock Read More Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Analysis of the daily limit of Jiashitang on April 6th Post date April 6, 2022 — 18:36 Post Lock Read More
Caishen.CoCaishen.Co